BillionToOne, Inc.(BLLN)

110.95+2.01+1.85%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元
  智通财经 · 06:00
  BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元
- 异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期
  异动解读 · 01:42
  异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期
- 异动解读 | BillionToOne上市首日，股价盘中大涨66.67%
  异动解读 · 01:42
  异动解读 | BillionToOne上市首日，股价盘中大涨66.67%
- BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股
  美股速递 · 10-29
  BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股
- 分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元每股定价49至55美元
  智通财经 · 10-20
  分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元每股定价49至55美元
公司概况
公司名称
BillionToOne, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.billiontoone.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了革命性的单分子NGS平台，能够以单分子灵敏度检测和精确定量基因靶点。公司的技术平台使其能够打造引领行业的产前和肿瘤产品。

分时
5日
日
周
月

数据加载中...

最高

112.20

今开

108.70

量比

1.14

最低

108.70

昨收

108.94

换手率

0.43%

热议股票

{"pagemeta":{"title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BillionToOne, Inc.,BLLN,BillionToOne, Inc.股票,BillionToOne, Inc.股票老虎,BillionToOne, Inc.股票老虎国际,BillionToOne, Inc.行情,BillionToOne, Inc.股票行情,BillionToOne, Inc.股价,BillionToOne, Inc.股市,BillionToOne, Inc.股票价格,BillionToOne, Inc.股票交易,BillionToOne, Inc.股票购买,BillionToOne, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"news","symbol":"BLLN","data":{"stockData":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":110.95,"timestamp":1762525987856,"preClose":108.94,"halted":0,"volume":16718,"delay":0,"floatShares":3846000,"shares":44015300,"eps":0,"marketStatus":"交易中","change":2.01,"latestTime":"11-07 09:33:14 EST","open":108.7,"high":112.195,"low":108.7,"amount":1822422.15844,"amplitude":0.032082,"askPrice":112,"askSize":50,"bidPrice":108,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1762549200000},"marketStatusCode":2,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":108.94,"preHourTrading":{"tag":"盘前","latestPrice":108.8,"preClose":108.94,"latestTime":"09:29 EST","volume":1272,"amount":136629.28512,"timestamp":1762525755119},"postHourTrading":{"tag":"盘后","latestPrice":109.98,"preClose":108.94,"latestTime":"19:59 EST","volume":30924,"amount":3291659.9104,"timestamp":1762477175445},"volumeRatio":1.139112},"tweetData":null,"newsData":{"listData":[{"id":"2581491700","title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581491700","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581491700?lang=zh_cn&edition=full","pubTime":"2025-11-07 06:00","pubTimestamp":1762466400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物分子诊断公司BillionToOne周四正式登陆纳斯达克，开盘股价暴涨，截至收盘，该股涨幅为81.57%，市值迅速升至近48亿美元，成为政府停摆背景下逆势上市的亮眼新股。BillionToOne此次发行价为60美元，开盘即跳涨至100美元，盘中最高逼近123.45美元。BillionToOne 目前位于加州门洛帕克，专注开发基于单分子测序技术的无创产前检测及肿瘤血液检测。在政府停摆持续、SEC审批程序受限的情况下，BillionToOne的成功上市被视为IPO市场回暖的重要信号。","market":"sh","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366325.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1147","BLLN","BK4007"],"gpt_icon":0},{"id":"1191654904","title":"异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191654904?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne, Inc.今日在纳斯达克首次公开交易，盘中大涨66.67%，引起市场广泛关注。据悉，BillionToOne的股票开盘价为每股100美元，较60美元的发行价大幅上涨66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价高于预期区间。总部位于加利福尼亚州门洛帕克市的BillionToOne主要开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。BillionToOne的强劲debut表明投资者对其业务前景及生物科技行业整体保持乐观态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1131573131","title":"异动解读 | BillionToOne上市首日，股价盘中大涨66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131573131?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne今日在纳斯达克证券交易所首次亮相，股价表现亮眼，盘中大涨66.67%，引发市场广泛关注。据悉，BillionToOne的IPO发行价为每股60美元，而开盘价高达100美元，较发行价溢价66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价明显高于预期区间。此次成功上市不仅为BillionToOne带来了可观的融资，也反映了投资者对其业务前景的看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1147084798","title":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147084798","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147084798?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:02","pubTimestamp":1761732155,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2576583836","title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576583836","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576583836?lang=zh_cn&edition=full","pubTime":"2025-10-20 15:38","pubTimestamp":1760945928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，分子诊断公司BillionToOne公布了其首次公开募股的条款。按照拟议价格区间的中点计算，BillionToOne 的完全稀释后市值将达到 27 亿美元。2019 年，该公司推出了其首款产前产品 UNITY，这是首个利用游离 DNA 进行隐性遗传病胎儿风险评估的无创产前检测，无需父亲样本或侵入性操作。BillionToOne 成立于 2016 年，专注于产前筛查和癌症治疗监测领域，其核心Quantitative Counting Templates技术能以单碱基对精度检测DNA分子。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLLN"],"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.billiontoone.com","stockEarnings":[{"period":"1week","weight":0.8157},{"period":"ytd","weight":0.8157}],"compareEarnings":[{"period":"1week","weight":-0.014},{"period":"1month","weight":0.0018},{"period":"3month","weight":0.052},{"period":"6month","weight":0.1878},{"period":"1year","weight":0.1341},{"period":"ytd","weight":0.1437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了革命性的单分子NGS平台，能够以单分子灵敏度检测和精确定量基因靶点。公司的技术平台使其能够打造引领行业的产前和肿瘤产品。","exchange":"NASDAQ","name":"BillionToOne, Inc.","nameEN":"BillionToOne, Inc."},"aProfile":null}}}